We are pleased to share with members the following information which was presented at the successful parliamentary event held on 10th...

We are delighted to be hosting a parliamentary event in December 2014, hosted by John Baron MP, Chair of the All-Party Parliamentary...

On 31st October 2014 Cancer52 submitted its response to the NHS England Consultation: Proposals for a sustainable Cancer Drugs Fund. You...

The National Cancer Patient Experience Survey 2014 was published this morning. Our comment on its publication is here.

Cancer52, an alliance of 80 charities working in the field of rare and less common cancers is today (19th September 2014) publishing its...

The Joint VBA Statement, prepared alongside Genetic Alliance UK, which nearly half our members signed, was submitted on Friday 12th...

Cancer52 welcomes the new additional investment of £160 million in the Cancer Drugs Fund (CDF) announced by Health Secretary Jeremy Hunt...

Cancer52 has commented on a number of aspects of the Methods of Technology Appraisals consultation, and submitted its response to NICE....

Please find here Cancer52's response to the NICE Methods of Technology Appraisal Consultation, which was submitted to NICE on Tuesday...

A new report published today (Tuesday 10th June 2014) by Cancer52 shows that the percentage of cancer deaths from those cancers outside...